GBI Research’s report, Methyl Tertiary Butyl Ether (MTBE) Global Markets to 2020 - China Dominates Global MTBE Demand While Developed Regions Look to ETBE and Ethanol as Replacement Options”, provides an in-depth analysis of the...
|
$ 3500
|
|
|
GBI Research, a leading business intelligence provider, has released its latest research, Refining Industry to 2017 - Asia-Pacific, Middle East and Africa to Emerge as Key Regions for Infrastructure Investments for Capacity Additions”...
|
$ 3500
|
|
|
GBI Research, the leading business intelligence provider, has released its latest research, e-Clinical Trial Solutions Market to 2018 - Growing Complexity of Clinical Trials and Increased Focus on Accuracy and Efficiency Drive Trial Sponsor...
|
$ 3500
|
|
|
GBI Research, a leading business intelligence provider, has released its latest research, entitled Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Target...
|
$ 3500
|
|
|
Leading business intelligence provider GBI Research has released its latest research report, entitled Sales Force Effectiveness in Pharmaceuticals - Targeted Sales Models such as Enhanced Key Account Management (KAM) and Closed-Loop Marketi...
|
$ 3500
|
|
|
GBI Research’s report, Endoscopy Devices Market to 2018 - Demand for Cost-Effective, Minimally Invasive Procedures and Reimbursement for New Indications to Increase Uptake” provides key data, information and analysis on the glob...
|
$ 3500
|
|
|
GBI Research’s report, Hospital Supplies Market to 2018 - Increasing Preference for Electro-mechanical Tables over Conventional Hydraulic Models to Drive Market Growth” provides key data, information and analysis on the global h...
|
$ 3500
|
|
|
GBI Research’s report, Neurostimulation Devices Market to 2018 - Technological Advances and Robust Pipeline with Multi-Indication Potential and Non-Invasive Therapies to Drive Growth”, provides key data, information and analysis...
|
$ 3500
|
|
|
Active Pharmaceutical Ingredients (API) Market in Europe to 2017 - Pricing and Reimbursement Initiatives Supporting Generic Drug Growth, with CMOs Expected to Account for Majority of the Manufacturing Activity
Summary
GBI Research’s report, “Ac
|
$ 3500
|
|
|
Major Power Markets in Eastern Europe to 2020 - Renewable Resources, Privatization, and Easing Barriers to Entry in Russia, Czech Republic, Poland, Ukraine and TurkeySummaryGBI Research, a leading business intelligence prov...
|
$ 3500
|
|
|
Emerging Power Markets in South-East Asia, Middle East and Africa to 2020 - Government’s Restructuring Reforms Encouraging Private Participation will Enhance Price Competition and Efficiency
Summary
GBI Research, a leading business intelligence
|
$ 3500
|
|
|
GBI Research, leading business intelligence provider, has released its latest research report, entitled Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to R...
|
$ 3500
|
|
|
Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline
Summary
GBI Research, the leading business intelligence provider, has released its latest research, “No
|
$ 3500
|
|
|
Biosimilars in Developed Countries - Launch of Biosimilar mAbs in Europe and New Regulatory Pathways in the US to Spur Market Growth
Summary
GBI Research, the leading business intelligence provider, has released its latest report, “Biosimilars
|
$ 3500
|
|
|
Biobanks - 2012 Year Book
Summary
GBI Research, the leading business intelligence provider, has released its latest report, “Biobanks - 2012 Year Book”. It provides key data, information and analysis of 37 of the world’s major biobanks. The rep
|
$ 3500
|
|
|
Protein and Peptide-based Therapeutics - Trends in Drug Discovery and Development
Summary
GBI Research, leading business intelligence provider, has released its latest research report, entitled “Protein and Peptide-based Therapeutics - Trends i
|
$ 3500
|
|
|
Biobetters in Key Markets - Opportunities for Biotechnology Companies to Sustain Innovation with Low Risk and High Value Offerings
Summary
GBI Research, the leading business intelligence provider, has released its latest research on, “Biobetter
|
$ 3500
|
|
|
Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise
Summary
GBI Research, the leading business intelligence provider, has released its latest research, “Multi-Targeted Therapies -
|
$ 3500
|
|
|
Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media
Summary
GBI Research, the leading business intelligence provider, has released its latest
|
$ 3500
|
|
|
Pharmaceutical Supply Chain in Europe - Adoption of Direct to Pharmacy (DTP) Model to Boost Efficiency and Optimize Pricing
Summary
GBI Research, leading business intelligence provider, has released its latest research report, entitled “Pharmac
|
$ 3500
|
|
|